Proteomics Market Research Report - Global Forecast till 2027

Proteomics Market Research Report: by Equipment (Chromatography, Mass Spectroscopy, Protein Microarray, Others), by Services (Laboratory Services, Data Analysis & Services), by Application (Drug Discovery, Clinical Diagnosis, Others) - Global Forecast Till 2027

ID: MRFR/LS/5465-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario:


Global Proteomics Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 23.2 Billion in 2017 and is projected to grow at a CAGR of 14.1% over the forecast period. Proteomes are a set of proteins which are produced in a system, organism, or any biological entity. Study of proteomes is known as proteomics. It is used in various applications, like investigation of protein expression, transcriptional & post transcriptional studies, metabolic pathways, protein interaction in diseases, etc.


The factors such as increasing research & development activities in the healthcare industry, rising demand for personalized medicines, rising number of approvals of personalized medicines and increasing activities of drug discovery are expected to propel the growth of the market. According to Foley & Lardner LLP, Food and Drug Administration (FDA) approved 16 new personalized medicine therapies in 2017. However, the high cost of devices and lack of skilled researchers can hamper the market growth over the forecast period.


Segmentation:


The Global Proteomics Market has been segmented into equipment, service and applicationThe market, on the basis of equipment, has been segmented into chromatography, mass spectroscopy, protein microarray, x-ray crystallography, protein fractionation and others.The market, by services, has been segmented into laboratory services and data analysis & services. The laboratory services segment accounted for the largest market share owing to its benefits in effective diagnosis and research for drug discovery. Data analysis and services is expected to register the highest CAGR owing to increasing demand for data analytics.The market, by application, has been segmented into drug discovery, clinical diagnosis and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Proteomics Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Proteomics Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Proteomics Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Proteomics market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players:


GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd., Thermo Fisher Scientific Inc. Inc., Agilent Technologies, Inc., Genzyme Corporation, Biognosys AG, Bruker, Luminex Corporation, Merck KGaA, PerkinElmer Inc., WATERS, Caprion Biosciences Inc. and others are some of the key players in the Global Proteomics Market.


Regional Market Summary


Global Proteomics Market Share (%), by Region, 2017


Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the global proteomics market owing to rising funding from government, rising awareness regarding applications of proteomics, cost effectiveness and increasing demand for personalized medicines. According to a report published in a journal named Leukemia Research in November 2017, personalized medicines improve life of cancer patients by 7 months at USD 32,000.


Europe is expected to hold the second largest position in the Global Proteomics Market. The market growth in this region is attributed to rising cancer research activities and government support. The proteomics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and the Rest of the Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increasing demand for personalized medicine due to rising prevalence of cancer and other such diseases and presence of large number of manufacturers of personalized medicines in the region. According to a report published by the National Institute of Cancer Prevention and Research (NICPR), around 2.25 million people in India are living with cancer in 2018.


The Middle East & Africa are expected to hold the least share of the market. The market growth in this region is expected to be driven by a developing healthcare infrastructure.


Global Proteomics Market, by Equipment:



  • Chromatography

  • Mass Spectroscopy

  • Protein Microarray

  • X-ray Crystallography

  • Protein Fractionation

  • Others


Global Proteomics Market, by Services:



  •       Laboratory Service

  •       Data Analysis and Services


Global Proteomics Market, by Application:



  •      Drug Discovery

  •      Clinical Diagnosis

  •      Others


Global Proteomics Market, by Region:



  • Americas

    •   North America

      •  US

      •  Canada



    •  South America



  • Europe

    •  Western Europe

      •  Germany

      •  France

      •  Italy

      •  Spain

      •  UK

      •  Rest of Western Europe



    •   Eastern Europe



  • Asia-Pacific

    •  Japan

    •  China

    •  India

    •  Australia

    •  South Korea

    •  Rest of Asia-Pacific



  • The Middle East & Africa

    •  Middle East

    •  Africa




Global Proteomics Market, by Key Players:



  •       Hoffmann-La Roche Ltd

  •       GENERAL ELECTRIC COMPANY

  •       Bio-Rad Laboratories, Inc.

  •       Danaher

  •       Siemens Ltd.

  •       Thermo Fisher Scientific Inc. Inc.

  •       Agilent Technologies, Inc.

  •       Genzyme Corporation

  •       Biognosys AG

  •       Bruker

  •       Luminex Corporation

  •       Merck KGaA

  •       PerkinElmer Inc.

  •       WATERS

  •       Caprion Biosciences Inc.


Intended Audience:



  • Pharmaceutical Companies

  • Research and Development Organization

  • Oncology Laboratories

  • Healthcare Organizations

  • Academics and Research Institutes


 


 


 


 



Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Equipment Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Proteomics Market, by Equipment

6.1 Introduction

6.2 Chromatography

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Mass Spectroscopy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Protein Microarray

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 X-ray Crystallography

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Protein Fractionation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Proteomics Market, by Service

7.1 Introduction

7.2 Laboratory Service

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Data Analysis and Services

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Proteomics Market, by Application

8.1 Introduction

8.2 Drug Discovery

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Clinical Diagnosis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Proteomics Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 GENERAL ELECTRIC COMPANY

11.1.1 Company Overview

11.1.2 Equipment Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Bio-Rad Laboratories, Inc.

11.2.1 Company Overview

11.2.2 Equipment Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 DANAHER

11.3.1 Company Overview

11.3.2 Equipment Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Siemens Ltd.

11.4.1 Company Overview

11.4.2 Equipment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Thermo Fisher Scientific Inc.

11.5.1 Company Overview

11.5.2 Equipment Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Agilent Technologies, Inc.

11.6.1 Company Overview

11.6.2 Equipment Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Genzyme Corporation

11.7.1 Overview

11.7.2 Equipment Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Biognosys AG

11.8.1 Overview

11.8.2 Equipment Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Bruker

11.9.1 Overview

11.9.2 Equipment Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Luminex Corporation

11.10.1 Overview

11.10.2 Equipment Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Merck KGaA

11.11.1 Overview

11.11.2 Equipment Overview

11.11.3 Financial Overview

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 PerkinElmer Inc.

11.12.1 Overview

11.12.2 Equipment Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 WATERS

11.13.1 Overview

11.13.2 Equipment Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Caprion Biosciences Inc.

11.14.1 Overview

11.14.2 Equipment Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Proteomics Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Proteomics Market Synopsis, 2020-2027

Table 2 Global Proteomics Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Proteomics Market, by Region, 2020-2027 (USD Million)

Table 4 Global Proteomics Market, by Equipment, 2020-2027 (USD Million)

Table 5 Global Proteomics Market, by Services, 2020-2027 (USD Million)

Table 6 Global Proteomics Market, by Application, 2020-2027 (USD Million)

Table 7 North America: Proteomics Market, by Equipment, 2020-2027 (USD Million)

Table 8 North America: Proteomics Market, by Services, 2020-2027 (USD Million)

Table 9 North America: Proteomics Market, by Application, 2020-2027 (USD Million)

Table 10 US: Proteomics Market, by Equipment, 2020-2027 (USD Million)

Table 11 US: Proteomics Market, by Services, 2020-2027 (USD Million)

Table 12 US: Proteomics Market, by Application, 2020-2027 (USD Million)

Table 13 Canada: Proteomics Market, by Equipment, 2020-2027 (USD Million)

Table 14 Canada: Proteomics Market, by Services, 2020-2027 (USD Million)

Table 15 Canada: Proteomics Market, by Application, 2020-2027 (USD Million)

Table 16 South America: Proteomics Market, by Equipment, 2020-2027 (USD Million)

Table 17 South America: Proteomics Market, by Services, 2020-2027 (USD Million)

Table 18 South America: Proteomics Market, by Application, 2020-2027 (USD Million)

Table 19 Europe: Proteomics Market, by Equipment, 2020-2027 (USD Million)

Table 20 Europe: Proteomics Market, by Services, 2020-2027 (USD Million)

Table 21 Europe: Proteomics Market, by Application, 2020-2027 (USD Million)

Table 22 Western Europe: Proteomics Market, by Equipment, 2020-2027 (USD Million)

Table 23 Western Europe: Proteomics Market, by Services, 2020-2027 (USD Million)

Table 24 Western Europe: Proteomics Market, by Application, 2020-2027 (USD Million)

Table 25 Eastern Europe: Proteomics Market, by Equipment, 2020-2027 (USD Million)

Table 26 Eastern Europe: Proteomics Market, by Services, 2020-2027 (USD Million)

Table 27 Eastern Europe: Proteomics Market, by Application, 2020-2027 (USD Million)

Table 28 Asia-Pacific: Proteomics Market, by Equipment, 2020-2027 (USD Million)

Table 29 Asia-Pacific: Proteomics Market, by Services, 2020-2027 (USD Million)

Table 30 Asia-Pacific: Proteomics Market, by Application, 2020-2027 (USD Million)

Table 31 Middle East & Africa: Proteomics Market, by Equipment, 2020-2027 (USD Million)

Table 32 Middle East & Africa: Proteomics Market, by Services, 2020-2027 (USD Million)

Table 33 Middle East & Africa: Proteomics Market, by Application, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Proteomics Market

Figure 3 Market Dynamics for Global Proteomics Market

Figure 4 Global Proteomics Market Share, by Equipment, 2020

Figure 5 Global Proteomics Market Share, by Services, 2020

Figure 6 Global Proteomics Market Share, by Application, 2020

Figure 7 Global Proteomics Market Share, by Region, 2020

Figure 8 North America: Proteomics Market Share, by Country, 2020

Figure 9 Europe: Proteomics Market Share, by Country, 2020

Figure 10 Asia-Pacific: Proteomics Market Share, by Country, 2020

Figure 11 Middle East & Africa: Proteomics Market Share, by Country, 2020

Figure 12 Global Proteomics Market: Company Share Analysis, 2020 (%)

Figure 13 GENERAL ELECTRIC COMPANY: Key Financials

Figure 14 GENERAL ELECTRIC COMPANY: Segmental Revenue

Figure 15 GENERAL ELECTRIC COMPANY: Geographical Revenue

Figure 16 Bio-Rad Laboratories, Inc.: Key Financials

Figure 17 Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 18 Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 19 DANAHER: Key Financials

Figure 20 DANAHER: Segmental Revenue

Figure 21 DANAHER: Geographical Revenue

Figure 22 Siemens Ltd.: Key Financials

Figure 23 Siemens Ltd.: Segmental Revenue

Figure 24 Siemens Ltd.: Geographical Revenue

Figure 25 Thermo Fisher Scientific Inc.: Key Financials

Figure 26 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 27 Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 28 Agilent Technologies, Inc.: Key Financials

Figure 29 Agilent Technologies, Inc.: Segmental Revenue

Figure 30 Agilent Technologies, Inc.: Geographical Revenue

Figure 31 Genzyme Corporation: Key Financials

Figure 32 Genzyme Corporation: Segmental Revenue

Figure 33 Genzyme Corporation: Geographical Revenue

Figure 34 Biognosys AG: Key Financials

Figure 35 Biognosys AG: Segmental Revenue

Figure 36 Biognosys AG: Geographical Revenue

Figure 37 Bruker: Key Financials

Figure 38 Bruker: Segmental Revenue

Figure 39 Bruker: Geographical Revenue

Figure 40 Luminex Corporation: Key Financials

Figure 41 Luminex Corporation: Segmental Revenue

Figure 42 Luminex Corporation: Geographical Revenue

Figure 43 Merck KGaA: Key Financials

Figure 44 Merck KGaA: Segmental Revenue

Figure 45 Merck KGaA: Geographical Revenue

Figure 46 PerkinElmer Inc.: Key Financials

Figure 47 PerkinElmer Inc.: Segmental Revenue

Figure 48 PerkinElmer Inc.: Geographical Revenue

Figure 49 WATERS: Key Financials

Figure 50 WATERS: Segmental Revenue

Figure 51 WATERS: Geographical Revenue

Figure 52 Caprion Biosciences Inc.: Key Financials

Figure 53 Caprion Biosciences Inc.: Segmental Revenue

Figure 54 Caprion Biosciences Inc.: Geographical Revenue